Ata uhi

Enhanced Delivery of 4-Thioureidoiminomethylpyridinium Perchlorate in Tuberculosis Models with IgG Functionalized Poly(Lactic Acid)-Based Particles

The compound 4-thioureidoiminomethylpyridinium perchlorate (perchlozone©) is a novel anti-tuberculosis drug that is active in multiple drug resistance cases, but the compound is hepatotoxic. To decrease the systemic load and to achieve targeting, we encapsulated the drug into poly(lactic ac...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Leonid Churilov (Author), Viktor Korzhikov-Vlakh (Author), Ekaterina Sinitsyna (Author), Dmitry Polyakov (Author), Oleg Darashkevich (Author), Mikhail Poida (Author), Galina Platonova (Author), Tatiana Vinogradova (Author), Vladimir Utekhin (Author), Natalia Zabolotnykh (Author), Vsevolod Zinserling (Author), Peter Yablonsky (Author), Arto Urtti (Author), Tatiana Tennikova (Author)
Hōputu:	Pukapuka
I whakaputaina:	MDPI AG, 2018-12-01T00:00:00Z.
Ngā marau:	article
Urunga tuihono:	Connect to this object online.
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite

Polymer Particles Bearing Recombinant LEL CD81 as Trapping Systems for Hepatitis C Virus
mā: Dmitry Polyakov, me ētahi atu.
I whakaputaina: (2021)

Nanomedicines Bearing an Alkylating Cytostatic Drug from the Group of 1,3,5-Triazine Derivatives: Development and Characterization
mā: Ekaterina Sinitsyna, me ētahi atu.
I whakaputaina: (2022)

Peptide Inhibitors of Vascular Endothelial Growth Factor A: Current Situation and Perspectives
mā: Ivan Guryanov, me ētahi atu.
I whakaputaina: (2021)

Amphiphilic Polypeptides for VEGF siRNA Delivery into Retinal Epithelial Cells
mā: Olga Osipova, me ētahi atu.
I whakaputaina: (2020)

Amphiphilic Polypeptides Obtained by Post-Polymerization Modification of Poly-<span style="font-variant: small-caps">l</span>-Lysine as Systems for Combined Delivery of Paclitaxel and siRNA
mā: Apollinariia Dzhuzha, me ētahi atu.
I whakaputaina: (2023)

Effect of Poly(L-lysine) and Heparin Coatings on the Surface of Polyester-Based Particles on Prednisolone Release and Biocompatibility
mā: Abdelrahman Mohamed, me ētahi atu.
I whakaputaina: (2021)

pH-Sensitive Chitosan-Heparin Nanoparticles for Effective Delivery of Genetic Drugs into Epithelial Cells
mā: Iuliia Pilipenko, me ētahi atu.
I whakaputaina: (2019)

Polypeptide-Based Systems: From Synthesis to Application in Drug Delivery
mā: Mariia Stepanova, me ētahi atu.
I whakaputaina: (2023)

Dracorhodin perchlorate regulates fibroblast proliferation to promote rat's wound healing
mā: Xiaowen Jiang, me ētahi atu.
I whakaputaina: (2018)

The Association Between Environmental Perchlorate, Nitrate, and Thiocyanate Exposure and Oral Pain in NHANES
mā: Jintao Yu, me ētahi atu.
I whakaputaina: (2022)

Dracorhodin Perchlorate Induces Apoptosis via Activation of Caspases and Generation of Reactive Oxygen Species
mā: Mingyu Xia, me ētahi atu.
I whakaputaina: (2004)

Combined metabolomics and network pharmacology to elucidate the mechanisms of Dracorhodin Perchlorate in treating diabetic foot ulcer rats
mā: Pin Deng, me ētahi atu.
I whakaputaina: (2022)

The risk of perchlorate and iodine on the incidence of thyroid tumors and nodular goiter: a case-control study in southeastern China
mā: Huirong Wang, me ētahi atu.
I whakaputaina: (2022)

Chaotropic effect of trifluoroacetic and perchloric acid on B-cyclodextrin inclusion complexation process with risperidone, olanzapine and their selected impurities
mā: Đajić Nevena, me ētahi atu.
I whakaputaina: (2020)

The association between perchlorate in drinking water and height and weight of children and adolescents in Southwest China: a retrospective cross-sectional study
mā: Hongyu Guo, me ētahi atu.
I whakaputaina: (2023)

Novel Formulations of C-Peptide with Long-Acting Therapeutic Potential for Treatment of Diabetic Complications
mā: Natalia Zashikhina, me ētahi atu.
I whakaputaina: (2019)

Dracorhodin perchlorate induces apoptosis in bladder cancer cells through Bcl-2, Bcl-XL, survivin down-regulation and caspase-3 activation
mā: Wei Wei, me ētahi atu.
I whakaputaina: (2013)

Crystal structure of the human carbonic anhydrase II adduct with 1-(4-sulfamoylphenyl-ethyl)-2,4,6-triphenylpyridinium perchlorate, a membrane-impermeant, isoform selective inhibitor
mā: Vincenzo Alterio, me ētahi atu.
I whakaputaina: (2018)

Coordination insertion of L-lactic acid
mā: Arpudsorn Thavornwan
I whakaputaina: (2014)

Lactic Acid Bacteria R & D for Food, Health and Livestock Purposes
I whakaputaina: (2013)

Polypeptide Self-Assembled Nanoparticles as Delivery Systems for Polymyxins B and E
mā: Dmitrii Iudin, me ētahi atu.
I whakaputaina: (2020)

Lactic acid as an adjuvant marker in pregnancyassociated sepsis
mā: R Agarwal, me ētahi atu.
I whakaputaina: (2018)

Lactic Acid Chemical Peeling in Skin Disorders
mā: Feng X, me ētahi atu.
I whakaputaina: (2024)

Potential use of lactic acid in obstetrics and gynecology
mā: A.M. Savicheva, me ētahi atu.
I whakaputaina: (2022)

Congenital Lactic Acidosis: PET and MRS Studies
mā: J Gordon Millichap
I whakaputaina: (1995)

Examination of Lactic Acid Bacteria to Secretion of Bacteriocins
mā: Maira Urazova, me ētahi atu.
I whakaputaina: (2014)

Lactic Acidosis Related to Pharmacotherapy and Human Diseases
mā: Christian Zanza, me ētahi atu.
I whakaputaina: (2022)

The Association Between Sarcopenia and Functional Improvement in Older and Younger Patients Who Completed Inpatient Rehabilitation: A Prospective Cohort Study
mā: Irina Churilov, me ētahi atu.
I whakaputaina: (2021)

Properties of Poly (Lactic-co-Glycolic Acid) and Progress of Poly (Lactic-co-Glycolic Acid)-Based Biodegradable Materials in Biomedical Research
mā: Yue Lu, me ētahi atu.
I whakaputaina: (2023)

Pullulan Based Bioconjugates for Ocular Dexamethasone Delivery
mā: Eva Kicková, me ētahi atu.
I whakaputaina: (2021)

Exopolysaccharide and lactic acid bacteria: Perception, functionality and prospects
mā: Vivek K. Bajpai, me ētahi atu.
I whakaputaina: (2015)

Solubility and ADMET profiles of short oligomers of lactic acid
mā: Daniela Dascălu, me ētahi atu.
I whakaputaina: (2020)

Thiamine-Responsive Congenital Lactic Acidosis Without MC
mā: J Gordon Millichap
I whakaputaina: (2005)

Neonatal Hypoglycemia, Lactic Acidosis, and Pyridoxine-Dependent Epilepsy
mā: J Gordon Millichap
I whakaputaina: (2012)

in vitro activation of complement and contact system by lactic acidosis
mā: J. Sonntag, me ētahi atu.
I whakaputaina: (1998)

The prevalence of sarcopenia in middle‐aged and older patients in post‐acute inpatient rehabilitation: a cross‐sectional study
mā: Irina Churilov, me ētahi atu.
I whakaputaina: (2021)

Pharmacokinetic Simulations of Intravitreal Biologicals: Aspects of Drug Delivery to the Posterior and Anterior Segments
mā: Anna-Kaisa Rimpelä, me ētahi atu.
I whakaputaina: (2018)

Retinal Pigment Epithelial Cell Line with Fast Differentiation and Improved Barrier Properties
mā: Laura Hellinen, me ētahi atu.
I whakaputaina: (2019)

Polysaccharides in Ocular Drug Delivery
mā: Natallia Dubashynskaya, me ētahi atu.
I whakaputaina: (2019)

Retraction: Hellinen et al. Retinal Pigment Epithelial Cell Line with Fast Differentiation and Improved Barrier Properties. <i>Pharmaceutics</i> 2019, <i>11</i>, 412
mā: Laura Hellinen, me ētahi atu.
I whakaputaina: (2022)